PVP Orphan Drug Price
Definition
The PVP orphan drug price represents contracted pricing available to PVP participants for orphan-designated drugs. Because certain hospital-type covered entities (RRCs, SCHs, CAHs, and CANs) are subject to the orphan drug exclusion—meaning manufacturers are not required to offer them 340B pricing on orphan drugs—the PVP negotiates voluntary pricing arrangements with manufacturers for these products.
The PVP orphan drug price applies to orphan drugs in the 340B account for the applicable covered entity types. It provides access to discounted pricing on orphan drugs that would otherwise not be subject to 340B pricing requirements.
Not all manufacturers participate in PVP orphan drug pricing, and not all orphan drugs will have PVP prices available. Covered entities subject to the orphan drug exclusion should check with Apexus to determine which orphan drugs have PVP pricing available.
Frequently Asked Questions
Why PVP Orphan Drug Price Matters
For covered entities subject to the orphan drug exclusion, the PVP orphan drug price provides an alternative mechanism for accessing discounted pricing on orphan-designated drugs that would otherwise be purchased at full price.
How Virtue 340B Uses It
Virtue 340B helps covered entities subject to the orphan drug exclusion identify and access PVP orphan drug pricing as part of our program optimization services.